Evidence map›Paper›PMID 27848971›Full record

ArticleNature communications2016

Epigenetic and genetic components of height regulation.

Stefania Benonisdottir, Asmundur Oddsson, Agnar Helgason, Ragnar P Kristjansson, Gardar Sveinbjornsson, Arna Oskarsdottir, Gudmar Thorleifsson, Olafur B Davidsson, Gudny A Arnadottir, Gerald Sulem and 18 more

Abstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The genetic basis of human height.Nature reviews. Genetics · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Parent-of-Origin inference for biobanks.Nature communications · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Stefania BenonisdottirdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Asmundur OddssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4606-5163
Agnar HelgasondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Ragnar P KristjanssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Gardar SveinbjornssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Arna OskarsdottirdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Gudmar ThorleifssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Olafur B DavidssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Gudny A ArnadottirdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Gerald SulemdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Brynjar O JenssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Hilma HolmdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Kristjan F AlexanderssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Laufey TryggvadottirFaculty of Medicine, University of Iceland, 101 Reykjavik, Iceland.
G Bragi WaltersdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-5415-6487
Sigurjon A GudjonssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Lucas D WarddeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Jon K SigurdssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Paul D IordachedeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Michael L FriggedeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-2984-535X
Thorunn RafnardeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Augustine KongdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Gisli MassondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Hannes HelgasondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Unnur ThorsteinsdottirdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Daniel F GudbjartssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.
Patrick SulemdeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-7123-6123
Kari StefanssondeCODE Genetics/Amgen, Inc., 101 Reykjavik, Iceland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult height is a highly heritable trait. Here we identified 31.6 million sequence variants by whole-genome sequencing of 8,453 Icelanders and tested them for association with adult height by imputing them into 88,835 Icelanders. Here we discovered 13 novel height associations by testing four different models including parent-of-origin (|β|=0.4-10.6 cm). The minor alleles of three parent-of-origin signals associate with less height only when inherited from the father and are located within imprinted regions (IGF2-H19 and DLK1-MEG3). We also examined the association of these sequence variants in a set of 12,645 Icelanders with birth length measurements. Two of the novel variants, (IGF2-H19 and TET1), show significant association with both adult height and birth length, indicating a role in early growth regulation. Among the parent-of-origin signals, we observed opposing parental effects raising questions about underlying mechanisms. These findings demonstrate that common variations affect human growth by parental imprinting.

Indexed as

Epigenesis, GeneticGenetic Association StudiesAdultBody HeightGenetic LociGenetic VariationGenotypeHumansIcelandModels, Genetic

Identifiers

PMID27848971
PMCPMC5116096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.